|
Market Closed -
Bombay S.E.
06:02:22 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 61.88 INR | +4.18% |
|
-1.54% | -22.89% |
| Market Cap | 1.77B 18.47M 15.82M 14.81M 13.55M 25.43M 25.77M 175M 68.22M 888M 69.36M 67.85M 2.94B | P/E 2025 |
-28.6x | P/E 2026 | 4.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.79B 18.67M 15.99M 14.96M 13.69M 25.7M 26.04M 177M 68.93M 897M 70.09M 68.56M 2.97B | EV / Sales 2025 |
3.93x | EV / Sales 2026 | 1.3x |
| Free-Float |
44.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +4.18% | ||
| 1 week | -1.54% | ||
| Current month | +1.44% | ||
| 1 month | -7.31% | ||
| 3 months | +20.09% | ||
| 6 months | -16.77% | ||
| Current year | -22.89% |
| 1 week | 58.26 |  | 62.41 |
| 1 month | 58.1 | | 67.95 |
| Current year | 36.9 | | 82.3 |
| 1 year | 36.9 | | 162.8 |
| 3 years | 36.9 | | 202.8 |
| 5 years | 36.9 | | 202.8 |
| 10 years | 14.05 | | 202.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Mahajan
CEO | Chief Executive Officer | 58 | 2002-01-22 |
Prashant Rathi
CEO | Chief Executive Officer | - | 2026-05-31 |
Atul Ranchal
PSD | President | 57 | 2023-08-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2022-11-22 | |
| Director/Board Member | 62 | 2010-09-09 | |
| Director/Board Member | - | 2023-08-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.18% | -1.54% | - | - | 18.47M | |
| -0.08% | -1.43% | +15.99% | +67.26% | 47.71B | |
| -3.21% | +1.37% | +52.36% | +125.75% | 40.3B | |
| -0.40% | -1.23% | -10.08% | +16.08% | 12.09B | |
| +1.11% | -1.34% | +13.61% | +71.49% | 11.68B | |
| 0.00% | +0.58% | +30.65% | +148.80% | 9.19B | |
| -0.39% | -0.92% | +19.81% | +39.54% | 7.57B | |
| -1.35% | +0.74% | +47.03% | -11.93% | 7.24B | |
| -0.64% | -0.02% | +19.42% | +199.06% | 6.84B | |
| -5.36% | -6.36% | -36.28% | +18.28% | 5.42B | |
| Average | -0.61% | -1.11% | +16.95% | +74.93% | 16.45B | |
| Weighted average by Cap. | -1.16% | -0.57% | +24.44% | +83.40% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 826M 8.63M 7.39M 6.92M 6.33M 11.88M 12.04M 81.71M 31.86M 415M 32.4M 31.69M 1.37B | 857M 8.96M 7.68M 7.18M 6.57M 12.34M 12.5M 84.86M 33.09M 431M 33.65M 32.92M 1.42B |
| Net income | -99.67M -1.04M -892K -835K -764K -1.43M -1.45M -9.86M -3.85M -50.07M -3.91M -3.83M -166M | 246M 2.57M 2.2M 2.06M 1.89M 3.54M 3.58M 24.33M 9.49M 123M 9.65M 9.44M 408M |
| Net Debt | 75.39M 788K 675K 632K 578K 1.08M 1.1M 7.46M 2.91M 37.87M 2.96M 2.89M 125M | 18.44M 193K 165K 154K 141K 265K 269K 1.82M 712K 9.26M 724K 708K 30.64M |
Employees
347
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ₹61.88 | +4.18% | 255 |
| 26-08-20 | ₹59.40 | -0.17% | 1,182 |
| 26-08-19 | ₹59.50 | +0.29% | 60 |
| 26-08-18 | ₹59.33 | -2.34% | 1,583 |
| 26-08-17 | ₹60.75 | -3.34% | 577 |
- Stock Market
- Stocks
- BROOKS Stock
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
